PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1681392
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1681392
Global Healthcare Cold Chain Third Party Logistics Market Size, Share, and Regional Forecasts 2022-2032
The global healthcare cold chain third-party logistics market is valued at USD 39.72 billion in 2023 and is expected to grow at a CAGR of 7.64% from 2024 to 2032, reaching USD 77.05 Billion by 2032. The growing demand for temperature-sensitive pharmaceuticals, biologics, vaccines, and medical devices, along with stringent regulatory requirements for storage and transportation, has significantly driven the expansion of third-party cold chain logistics solutions globally. Increasing outsourcing of logistics services by pharmaceutical and biotech companies has further strengthened market growth, as companies focus on cost optimization and operational efficiency.
The surge in personalized medicine, biologics, and cell & gene therapies has intensified the need for specialized cold chain logistics services that provide ultra-low temperature storage, real-time monitoring, and secure transportation. Biologics and mRNA-based vaccines, requiring stringent temperature control at -20°C, -80°C, and even cryogenic storage (-150°C or lower), are fueling investments in advanced cold storage infrastructure. Logistics providers are enhancing capabilities by integrating IoT-enabled sensors, blockchain-based supply chain tracking, and AI-driven route optimization to ensure temperature integrity and regulatory compliance throughout the supply chain.
The industry is witnessing significant technological advancements in automated cold storage warehouses, temperature-sensitive drone delivery, and AI-powered risk management solutions. For instance, in May 2023, DHL invested USD 1.5 million in developing temperature-controlled air freight services for biologics and pharmaceuticals, strengthening the industry's logistics capabilities for ultra-sensitive products.
Regional Insights-North America dominated the market in 2024, holding 33.1% of the global market share, primarily due to the highly developed pharmaceutical industry, strict FDA regulations, and widespread adoption of IoT-driven cold chain logistics solutions. The U.S. market is projected to grow further with the expansion of biologics production and increased reliance on third-party logistics (3PL) providers for temperature-sensitive product distribution.
Asia-Pacific is set to exhibit the highest CAGR during the forecast period, fueled by expanding pharmaceutical manufacturing in China and India, increasing vaccine exports, and improving cold chain infrastructure. Government-led investments in GDP-compliant cold storage solutions and high-tech logistics networks are propelling market growth.
Europe is another key regional player, with Germany, the UK, and France leading in automated cold storage facilities, blockchain-integrated supply chains, and AI-powered logistics optimization. Germany, in particular, is focusing on sustainable logistics, investing in hydrogen-powered refrigerated trucks and green warehouses.
Latin America and the Middle East & Africa (MEA) are witnessing steady growth, supported by rising pharmaceutical demand, vaccine distribution efforts, and increasing regulatory enforcement for cold chain logistics compliance. Countries like Brazil, Mexico, Saudi Arabia, and South Africa are actively investing in cold storage warehouses and temperature-controlled transportation networks.
Major Market Players
- DHL Group
- UPS
- FedEx
- Cardinal Health
- Kuehne + Nagel
- DB Schenker
- Agility
- SF Express
- Barrett Distribution Centers
- AmerisourceBergen
- Kinesis
Market Segmentation
By Service:
- Transportation
- Air Freight
- Sea Freight
- Overland
- Warehousing & Storage
- Packaging Solutions
- Monitoring & Visibility Solutions
- Inventory Management
- Others
By Product:
- Biopharmaceuticals
- Pharmaceuticals
- Medical Devices
- Others
By Temperature Range:
- Frozen (-20°C to -80°C)
- Ultra-frozen/Deep Frozen (-80°C to -150°C)
- Cryogenic (< -150°C)
By End Use:
- Pharmaceutical & Biopharmaceutical Companies
- Medical Device Companies
- Others
By Region:
North America:
- U.S.
- Canada
- Mexico
Europe:
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific:
- Japan
- China
- India
- South Korea
- Australia
- Thailand
Latin America:
- Brazil
- Argentina
Middle East & Africa:
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Years Considered for the Study:
- Historical Data: 2022
- Base Year: 2023
- Forecast Period: 2024-2032
Key Takeaways:
- Market Estimates & Forecasts for 10 years (2022-2032)
- Annualized revenues and regional-level analysis for each market segment
- Detailed analysis of geographical landscape with country-level insights
- Competitive landscape with key market players and strategies
- Analysis of demand-side and supply-side market trends
- Regulatory framework assessment for compliance and growth opportunities
Table of Contents
Chapter 1. Global Healthcare Cold Chain Third Party Logistics Market Executive Summary
- 1.1. Global Healthcare Cold Chain Third Party Logistics Market Size & Forecast (2022-2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Service
- 1.3.2. By Product
- 1.3.3. By Temperature Range
- 1.3.4. By End Use
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Healthcare Cold Chain Third Party Logistics Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory Frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
Chapter 3. Global Healthcare Cold Chain Third Party Logistics Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Rising demand for biologics, vaccines, and temperature-sensitive pharmaceuticals
- 3.1.2. Stringent regulatory requirements for pharmaceutical cold chain logistics
- 3.1.3. Increasing outsourcing of logistics operations by pharmaceutical companies
- 3.2. Market Challenges
- 3.2.1. High operational costs of cold chain infrastructure
- 3.2.2. Complexity in maintaining regulatory compliance across global supply chains
- 3.3. Market Opportunities
- 3.3.1. Adoption of IoT, AI, and blockchain for real-time tracking
- 3.3.2. Growth in personalized medicine and cell & gene therapies
- 3.3.3. Expansion of cold chain infrastructure in emerging markets
Chapter 4. Global Healthcare Cold Chain Third Party Logistics Market Industry Analysis
- 4.1. Porter's Five Forces Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's Five Forces Model
- 4.1.7. Porter's Five Forces Impact Analysis
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top Investment Opportunity
- 4.4. Top Winning Strategies
- 4.5. Disruptive Trends
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Healthcare Cold Chain Third Party Logistics Market Size & Forecasts by Service 2022-2032
- 5.1. Segment Dashboard
- 5.2. Global Healthcare Cold Chain Third Party Logistics Market: Service Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Transportation
- Air Freight
- Sea Freight
- Overland
- 5.2.2. Warehousing & Storage
- 5.2.3. Packaging Solutions
- 5.2.4. Monitoring & Visibility Solutions
- 5.2.5. Inventory Management
- 5.2.6. Others
Chapter 6. Global Healthcare Cold Chain Third Party Logistics Market Size & Forecasts by Product 2022-2032
- 6.1. Segment Dashboard
- 6.2. Global Healthcare Cold Chain Third Party Logistics Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Biopharmaceuticals
- 6.2.2. Pharmaceuticals
- 6.2.3. Medical Devices
- 6.2.4. Others
Chapter 7. Global Healthcare Cold Chain Third Party Logistics Market Size & Forecasts by Temperature Range 2022-2032
- 7.1. Segment Dashboard
- 7.2. Global Healthcare Cold Chain Third Party Logistics Market: Temperature Range Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Frozen (-20°C to -80°C)
- 7.2.2. Ultra-frozen/Deep Frozen (-80°C to -150°C)
- 7.2.3. Cryogenic (< -150°C)
Chapter 8. Global Healthcare Cold Chain Third Party Logistics Market Size & Forecasts by End Use 2022-2032
- 8.1. Segment Dashboard
- 8.2. Global Healthcare Cold Chain Third Party Logistics Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Pharmaceutical & Biopharmaceutical Companies
- 8.2.2. Medical Device Companies
- 8.2.3. Others
Chapter 9. Global Healthcare Cold Chain Third Party Logistics Market Size & Forecasts by Region 2022-2032
- 9.1. North America Healthcare Cold Chain Third Party Logistics Market
- 9.1.1. U.S. Healthcare Cold Chain Third Party Logistics Market
- 9.1.2. Canada Healthcare Cold Chain Third Party Logistics Market
- 9.1.3. Mexico Healthcare Cold Chain Third Party Logistics Market
- 9.2. Europe Healthcare Cold Chain Third Party Logistics Market
- 9.2.1. UK Healthcare Cold Chain Third Party Logistics Market
- 9.2.2. Germany Healthcare Cold Chain Third Party Logistics Market
- 9.2.3. France Healthcare Cold Chain Third Party Logistics Market
- 9.2.4. Italy Healthcare Cold Chain Third Party Logistics Market
- 9.2.5. Spain Healthcare Cold Chain Third Party Logistics Market
- 9.2.6. Denmark Healthcare Cold Chain Third Party Logistics Market
- 9.2.7. Sweden Healthcare Cold Chain Third Party Logistics Market
- 9.2.8. Norway Healthcare Cold Chain Third Party Logistics Market
- 9.3. Asia-Pacific Healthcare Cold Chain Third Party Logistics Market
- 9.3.1. China Healthcare Cold Chain Third Party Logistics Market
- 9.3.2. India Healthcare Cold Chain Third Party Logistics Market
- 9.3.3. Japan Healthcare Cold Chain Third Party Logistics Market
- 9.3.4. Australia Healthcare Cold Chain Third Party Logistics Market
- 9.3.5. South Korea Healthcare Cold Chain Third Party Logistics Market
- 9.3.6. Thailand Healthcare Cold Chain Third Party Logistics Market
- 9.4. Latin America Healthcare Cold Chain Third Party Logistics Market
- 9.4.1. Brazil Healthcare Cold Chain Third Party Logistics Market
- 9.4.2. Argentina Healthcare Cold Chain Third Party Logistics Market
- 9.5. Middle East & Africa Healthcare Cold Chain Third Party Logistics Market
- 9.5.1. Saudi Arabia Healthcare Cold Chain Third Party Logistics Market
- 9.5.2. South Africa Healthcare Cold Chain Third Party Logistics Market
- 9.5.3. UAE Healthcare Cold Chain Third Party Logistics Market
- 9.5.4. Kuwait Healthcare Cold Chain Third Party Logistics Market
Chapter 10. Competitive Intelligence
- 10.1. Key Company SWOT Analysis
- 10.1.1. DHL Group
- 10.1.2. UPS
- 10.1.3. FedEx
- 10.2. Top Market Strategies
- 10.3. Company Profiles
- 10.3.1. DHL Group
- 10.3.2. UPS
- 10.3.3. FedEx
- 10.3.4. Cardinal Health
- 10.3.5. Kuehne + Nagel
- 10.3.6. DB Schenker
